A Polymeric Nanoparticle to Co‐Deliver Mitochondria‐Targeting Peptides and Pt(IV) Prodrug: Toward High Loading Efficiency and Combination Efficacy

Jinpeng Yang,Zhenlin Yang,Hua Wang,Yincheng Chang,Jiang-Fei Xu,Xi Zhang

DOI: https://doi.org/10.1002/anie.202402291

2024-02-23

Angewandte Chemie International Edition

Abstract:Developing combination chemotherapy systems with high drug loading efficiency at predetermined drug ratios to achieve a synergistic effect is important for cancer therapy. Herein, a polymeric dual-drug nanoparticle composed of a Pt(IV) prodrug derived from oxaliplatin and a mitochondria-targeting cytotoxic peptide is constructed through emulsion interfacial polymerization, which processes high drug loading efficiency and high biocompatibility. The depolymerization of polymeric dual-drug nanoparticle and the activation of Pt prodrug can be effectively triggered by the acidic tumor environment extracellularly and the high levels of glutathione intracellularly in cancer cells, respectively. The utilization of mitochondria-targeting peptide can inhibit ATP-dependent processes including drug efflux and DNA damage repair. This leads to increased accumulation of Pt-drugs within cancer cells. Eventually, the polymeric dual-drug nanoparticle demonstrates appreciable antitumor effects on both cell line derived and patient derived xenograft lung cancer model. It is highly anticipated that the polymeric dual-or multi-drug systems can be applied for combination chemotherapy to achieve enhanced anticancer activity and reduced side effects.

chemistry, multidisciplinary

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop an efficient combined chemotherapy system to achieve a high drug - loading efficiency at a predetermined drug ratio, thereby achieving a synergistic anti - cancer effect. Specifically, the researchers designed a polymeric nanoparticle (PDDN) for simultaneously delivering a mitochondrial - targeting peptide and a platinum(IV) prodrug, aiming to overcome the limitations of traditional platinum - based drugs in cancer treatment.

### Main Problems and Solutions

1. **Improve Drug - Loading Efficiency**:
- Traditional drug carriers have problems such as low drug - loading efficiency and poor biocompatibility.
- The researchers constructed polymeric dual - drug nanoparticles (PDDN) by the emulsion - interface - polymerization method, achieving an almost 100% drug - loading efficiency.

2. **Achieve Synergistic Chemotherapy Effect**:
- Single - drug treatment is often of limited effectiveness, and high doses may lead to severe side effects.
- By precisely controlling the ratio of the mitochondrial - targeting peptide and the platinum(IV) prodrug, the researchers achieved the synergy between the two, enhancing the anti - cancer activity and reducing side effects.

3. **Overcome the Limitations of Platinum - Based Drugs**:
- The decreased intracellular accumulation of platinum - based drugs, drug inactivation, and DNA - damage repair are the main reasons for the decline in their anti - cancer activity.
- The mitochondrial - targeting peptide can inhibit ATP - dependent processes (such as drug efflux and DNA - damage repair), thereby increasing the intracellular accumulation of platinum - based drugs in cancer cells.

4. **Respond to the Tumor Microenvironment**:
- PDDN can depolymerize in the acidic tumor microenvironment and be activated by exogenous glutathione (GSH) to convert the platinum(IV) prodrug into the active form of platinum(II), thereby exerting an anti - cancer effect.

### Experimental Verification

- **In Vitro Experiments**: Through cytotoxicity experiments and 3D spheroid model experiments, the selective killing effect and synergistic effect of PDDN on cancer cells were verified.
- **In Vivo Experiments**: Using mouse xenograft models (CDX and PDX), it was proved that PDDN significantly inhibits tumor growth, and has good biocompatibility and low side effects.

### Conclusion

Through the above research, the researchers successfully developed a new type of polymeric nanoparticle, which not only improves the drug - loading efficiency but also achieves a synergistic chemotherapy effect, providing new ideas and methods for cancer treatment.